Increases in the Risk of Cognitive Impairment and Alterations of Cerebral β-amyloid Metabolism in Mouse Model of Heart Failure

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Hong, Xiaoqi ^a   Bu, Liping ^a   Wang, Yi ^a   Xu, Jing ^a   Wu, Jian ^a   Huang, Yufang ^a   Liu, Jie ^a   Suo, Haiyun ^a   Yang, Lumeng ^a   Shi, Yuncen ^a   Lou, Yi ^a   Sun, Zhengliang ^a   Zhu, Guoqi ^a   Behnisch, Thomas ^a   Yu, Mei ^a   Jia, Jianguo ^a   Hai, Wangxi ^b   Meng, Hongping ^c   Liang, Sheng ^c   Huang, Fang ^a   Zou, Yunzeng ^a   Ge, Junbo ^a   more..

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; INTERLEUKIN 6; PROTEIN BAX; TAU PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN REGION; CELL SURVIVAL; CEREBELLUM; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HEART FAILURE; HIPPOCAMPUS; LEARNING; LOCOMOTION; MALE; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANXIETY; APOPTOSIS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; COGNITION; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE; HEART FAILURE; LEARNING; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RISK; SEX CHARACTERISTICS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION, GENETIC;

MUS;

EID: 84878483683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063829     Document Type: Article

References (49)

1. Jefferson AL, Himali JJ, Au R, Seshadri S, Decarli C, et al. (2011) Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study). Am J Cardiol 108: 1346-1351.
2. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, et al. (2006) Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med 166: 1003-1008.
3. Jefferson AL, Himali JJ, Beiser AS, Au R, Massaro JM, et al. (2010) Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 122: 690-697.
4. de Toledo Ferraz Alves TC, Ferreira LK, Wajngarten M, Busatto GF, (2010) Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis 20: 749-763.
5. Sanbe A, Osinska H, Villa C, Gulick J, Klevitsky R, et al. (2005) Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 102: 13592-13597.
6. Kang D, Hamasaki N, (2005) Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 12: 429-441.
7. Mariani E, Polidori MC, Cherubini A, Mecocci P, (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827: 65-75.
8. de la Torre JC, (2008) Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis 5: 126-132.
9. de la Torre JC, (2006) How do heart disease and stroke become risk factors for Alzheimer's disease? Neurol Res 28: 637-644.
10. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, et al. (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63: 509-512.
11. Polidori MC, Mariani E, Mecocci P, Nelles G, (2006) Congestive heart failure and Alzheimer's disease. Neurol Res 28: 588-594.
12. Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, et al. (2001) Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 32: 2530-2533.
13. Alves TC, Busatto GF, (2006) Regional cerebral blood flow reductions, heart failure and Alzheimer's disease. Neurol Res 28: 579-587.
14. Mazza M, Marano G, Traversi G, Bria P, Mazza S, (2011) Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis 23: 375-389.
15. Langston RF, Stevenson CH, Wilson CL, Saunders I, Wood ER, (2010) The role of hippocampal subregions in memory for stimulus associations. Behav Brain Res 215: 275-291.
16. Grubb NR, Simpson C, Fox KA, (2000) Memory function in patients with stable, moderate to severe cardiac failure. Am Heart J 140: E1-5.
17. Vogels RL, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, et al. (2007) Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc 55: 1764-1770.
18. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC, (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9: 440-449.
19. Laudisio A, Marzetti E, Pagano F, Cocchi A, Bernabei R, et al. (2009) Digoxin and cognitive performance in patients with heart failure: a cohort, pharmacoepidemiological survey. Drugs Aging 26: 103-112.
20. Jeschke E, Ostermann T, Vollmar HC, Tabali M, Schad F, et al. (2011) Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians. BMC Neurol 11: 99.
21. Rattinger GB, Dutcher SK, Chhabra PT, Franey CS, Simoni-Wastila L, et al. (2012) The effect of dementia on medication use and adherence among medicare beneficiaries with chronic heart failure. Am J Geriatr Pharmacother 10: 69-80.
22. Kumar D, Hacker TA, Buck J, Whitesell LF, Kaji EH, et al. (2005) Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron Artery Dis 16: 41-44.
23. Wu J, Bu L, Gong H, Jiang G, Li L, et al. (2010) Effects of heart rate and anesthetic timing on high-resolution echocardiographic assessment under isoflurane anesthesia in mice. J Ultrasound Med 29: 1771-1778.
24. Aksentijevic D, Lygate CA, Makinen K, Zervou S, Sebag-Montefiore L, et al. (2010) High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes. Eur J Heart Fail 12: 1282-1289.
25. Prut L, Belzung C, (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 463: 3-33.
26. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, et al. (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. Embo Journal 17: 886-897.
27. Vorhees CV, Williams MT, (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols 1: 848-858.
28. Morris R, (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
29. Belayev L, Busto R, Zhao W, Ginsberg MD, (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739: 88-96.
30. Bian M, Liu J, Hong X, Yu M, Huang Y, et al. (2012) Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. PLoS One 7: e39953.
31. Yu M, Suo H, Liu M, Cai L, Liu J, et al. (2013) NRSF/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP. Neurobiol Aging 34: 916-927.
32. Busche MN, Stahl GL (2010) Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury. Ger Med Sci 8.
33. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, et al. (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17: 157-165.
34. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, et al. (1999) Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99: 3063-3070.
35. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, et al. (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104: 1286-1291.
36. Hattori T, Shimokawa H, Higashi M, Hiroki J, Mukai Y, et al. (2004) Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 109: 2234-2239.
37. Lund GK, Watzinger N, Saeed M, Reddy GP, Yang M, et al. (2003) Chronic heart failure: global left ventricular perfusion and coronary flow reserve with velocity-encoded cine MR imaging: initial results. Radiology 227: 209-215.
38. Chatterjee K, Massie B, (2007) Systolic and diastolic heart failure: differences and similarities. Journal of Cardiac Failure 13: 569-576.
39. Ashrafian H, Frenneaux MP, Opie LH, (2007) Metabolic mechanisms in heart failure. Circulation 116: 434-448.
40. Silverman DH, Phelps ME, (2001) Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Mol Genet Metab 74: 128-138.
41. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, et al. (2011) Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 77: 1977-1985.
42. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
43. Furukawa K, Okamura N, Tashiro M, Waragai M, Furumoto S, et al. (2010) Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET. J Neurol 257: 721-727.
44. Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, et al. (2010) Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Neuroimage 52: 488-496.
45. Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, et al. (2008) PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29: 1456-1465.
46. Manabe I, (2011) Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 75: 2739-2748.
47. Zhang T, Pan BS, Zhao B, Zhang LM, Huang YL, et al. (2009) Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains. Neuroscience 161: 1045-1056.
48. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, et al. (2003) Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 65: 119-128.
49. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, et al. (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A.